October 23rd 2024
For psychiatrists, can a poorly made film contain themes worthy of analysis?
2023 Annual Psychiatric Times™ World CME Conference
View More
5th Annual International Congress on the Future of Neurology®
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Real Psychiatry 2025
January 17 - 18, 2025
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Southern California Psychiatry Conference
July 11-12, 2025
Register Now!
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea
View More
Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia
View More
Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment
View More
Should Psychiatrists Prescribe Neuroenhancers for Mentally Healthy Patients?
April 2nd 2011As experts in neurobiology, we can conduct and critically evaluate research to identify the short- and long-term risks and benefits of neuroenhancers for patients without recognized clinical indications.
Read More
Psychiatry: Awaken and Return to the Path
March 22nd 2011Addressing a few subjects that may have the potential to create a more insidious and enduring form of misrepresentation ... namely, the implications that psychiatrists must now “play the game,” and resign themselves to a bleak future of harried pill dispensing.
Read More
Jared Loughner, Mental Illness, and the Media: Debating the Potential Impact of Media Coverage
February 15th 2011On January 24, Dr Ronald Pies posted a thoughtful piece titled “Who Can Forgive Jared Loughner?” which advocates the importance of relinquishing hatred in cases like the ones in Tucson and transforming “our revulsion and rage into something higher and nobler.”
Read More
Boycotts and Protests To Meet APA Keynote Speaker, Desmond Tutu
February 2nd 2011The selection of Archbishop Emeritus Desmond Tutu, 1984 Nobel Peace Prize recipient, to present the convocation lecture at the American Psychiatric Association’s upcoming annual meeting has so outraged some APA members that they have arranged meeting boycotts and protests.
Read More
Understanding and Overcoming the Myths of Suicide
January 20th 2011What goes on in the minds of those who attempt suicide? Here: a psychologist who explores the myths that surround suicide notes "We need to get it in our heads that suicide is not easy, painless, cowardly, selfish, vengeful, self-masterful, nor rash."
Read More
A Conversation With Dr Richard Kogan
November 29th 2010Creative people tend to see the world in novel and unconventional ways, and they often seek out intense and destabilizing experiences. Creative ideas are frequently generated during chaotic mental states characterized by loosening of associations that resemble the psychosis of mania or schizophrenia.
Read More
Review of Darryl Cunningham's Psychiatric Tales
November 17th 2010In this autobiographic work, Darryl Cunningham explains mental illness in a succinct and novel way. It is already proving to be of use to both health professionals and mental health service clients. Published in the UK this year, its US release is scheduled for February 2011.
Read More
Prime Time: Maximizing the Therapeutic Experience-A Primer for Psychiatric Clinicians
October 29th 2010The preface explains why Prime Time is so needed. It provides a refreshing, nonjudgmental summary of how and why we’ve arrived at the 20-minute hour. This is important for disgruntled clinicians from the “good old days” as well as for early-career clinicians who have not learned anything better.
Read More
Grief and Depression Redux: Response to Dr Frances’s “Compromise”
September 28th 2010Clearly, we all share the goals of respecting-not “medicalizing”-ordinary grief; as well as recognizing and treating clinically significant depression. We differ with Dr Frances in how to achieve these goals, while remaining faithful to the best available scientific data.
Read More
The Cultural Dimension in DSM-5: PTSD
August 15th 2010Any effort to develop a diagnostic manual for world-wide use must grapple with the question of cross-cultural applicability. The description and diagnostic criteria for schizophrenia must work as well in East Timor as in the US or France. In this piece I choose PTSD to show the complexity of the cultural issue for DSM-5.
Read More
FDA Lacks Desire for Flibanserin-But Does Hypoactive Sexual Desire Disorder Even Exist?
August 4th 2010Consider the predicament of Mrs M, a 38-year-old premenopausal mother of two. Mrs M tells her primary care physician, “I just don’t have a strong desire for sex. It’s been about 10 years now, and I hardly ever have sexual thoughts or fantasies.
Read More
DSM-5: Continuing the Confusion about Aging, Alzheimer’s and Dementia
July 15th 2010Since the early twentieth century, when Alois Alzheimer and Emil Kraepelin constructed it as a unified clinical-pathological entity, Alzheimer’s disease has been both one of the most stable and one of the most problematic neuropsychiatric entities.
Read More